GE Aerospace announced a multi‑year agreement with Saudi Arabia’s Saudia Group to supply 39 GEnx‑1B engines for the airline’s Boeing 787‑9 and 787‑10 fleet. The contract includes engine deliveries, a long‑term maintenance, repair and overhaul (MRO) program, spare engines, and a technical training and knowledge‑transfer initiative through Saudia Technic.
The deal strengthens GE Aerospace’s foothold in the Middle East, a key growth region for commercial aviation. By embedding local MRO capabilities and training Saudi technicians, the partnership aligns with Saudi Vision 2030’s goal of developing a high‑skill aerospace workforce and reducing reliance on foreign maintenance services.
GE Aerospace’s Q3 2025 earnings—revenue of $12.2 billion and adjusted EPS of $1.66—highlight the company’s robust performance. Services revenue grew 28% and commercial engine deliveries rose 33%, underscoring the firm’s capacity to secure large, multi‑year contracts such as this one.
Saudia Group’s Director General Ibrahim Al‑Omar said the partnership “transforms the Group’s long‑haul capability and expands our air connectivity, while accelerating the localization of high‑technology aviation expertise in the Kingdom.” GE Aerospace Chairman and CEO H. Lawrence Culp added that the GEnx engines will deliver “reliability, efficiency and durability” for Saudia’s fleet and that the collaboration will benefit both countries’ aerospace workforces.
The agreement adds a substantial order to GE Aerospace’s backlog and signals continued momentum in the Middle East. The combination of engine supply, MRO services, and workforce development positions GE Aerospace to capture further market share in the region and supports its broader strategy of expanding technical capabilities and local support for Saudi airlines.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.